Browsing Tag
Y-mAbs Therapeutics
2 posts
Y-mAbs Therapeutics showcases promising CD38-SADA translational pharmacokinetics data at AACR 2025
Find out how Y-mAbs’ CD38-SADA translational pharmacokinetics study at AACR 2025 is advancing next-gen cancer therapies with promising clinical insights.
Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma
US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab…